查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1699294

心血管设备市场机会、成长动力、产业趋势分析及 2025-2034 年预测

Cardiovascular Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球心血管设备市场价值为 75 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 13.5%，这得益于心血管疾病 (CVD) 病例的增加、技术进步和医疗保健支出的增加。心臟相关疾病的负担不断加重，主要原因是人口老化和生活方式相关的疾病，这极大地推动了对先进心血管解决方案的需求。由于久坐习惯、不良饮食选择和高压力水平继续导致全球心血管疾病，对创新诊断和治疗设备的需求变得比以往任何时候都更加迫切。此外，人们对预防性医疗保健和早期检测策略的认识不断提高，进一步推动了市场采用。

心血管设备市场 - IMG1

医疗技术的尖端进步正在彻底改变心血管护理。人工智慧诊断、机器人辅助手术和微创手术的引入正在改善患者的治疗效果，同时缩短恢復时间。该行业正在经历监管审批的激增，扩大了获得最先进心血管设备的机会。政府和私人医疗保健实体正在大力投资研发，以推出满足不断变化的患者需求的下一代解决方案。医疗保健支出的不断增长，尤其是在已开发经济体中，促进了先进心臟设备的广泛普及，进一步推动了市场的成长。此外，门诊心血管介入和家庭监测系统数量的增加使患者能够更方便地接受治疗。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 75亿美元
预测值 263亿美元
复合年增长率 13.5％

根据设备类型，市场分为心臟消融设备、左心耳封堵器和内视镜血管采集设备。其中，心臟消融设备占据市场主导地位，2024 年估值达 51 亿美元，预计预测期内复合年增长率为 13.7%。心房颤动盛行率的上升是这些设备需求增加的一个主要驱动因素。随着越来越多的人被诊断出患有心律不齐，微创消融技术的采用正在增加。此外，人们对有效治疗方案的认识不断提高，加上消融技术的不断进步，正在促进市场扩张。

根据最终用途，心血管设备市场分为医院、门诊手术中心、心臟中心和其他医疗机构。医院在该领域占据主导地位，2024 年创造了 44 亿美元的收入，占总收入的 58.3%。接受心臟绕道手术、导管插入术和设备植入等复杂心臟干预的患者数量不断增加，巩固了医院在这一领域的领导地位。医院配备了先进的影像技术、专门的心臟科和多学科团队，仍然是危重心血管病例的主要治疗中心。此外，他们处理紧急和住院手术的能力使他们成为患者和医疗保健提供者的首选。

2023 年，美国心血管设备市场规模为 25 亿美元，预计 2034 年将成长至 97 亿美元。美国拥有完善的医疗保健基础设施、尖端心血管技术的快速应用以及强大的熟练专业人员网络，包括心臟外科医生、介入性心臟病专家和电生理学家。治疗方法的不断创新和支持性监管政策正在加速市场渗透。优惠的报销框架进一步鼓励采用先进的心血管设备，使美国成为心臟护理解决方案的领先市场。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 心血管疾病患者数量不断增加
      • 老年人口不断增加
      • 政府措施不断涌现
      • 心血管设备的技术进步
      • 微创手术需求不断成长
    • 产业陷阱与挑战
      • 心臟手术的高风险
      • 严格的监管情景
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 未来市场趋势
  • 差距分析
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：按设备类型，2021 年至 2034 年

  • 主要趋势
  • 心臟消融设备
    • 射频消融仪
    • 电动消融器
    • 冷冻消融设备
    • 超音波设备
    • 其他心臟消融设备
  • 左心耳封堵器
    • 心内左心耳封堵器
    • 心外膜左心耳封堵器
  • 内视镜血管采集装置
    • EVH 系统
    • 内视镜
    • 配件

第六章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 心臟中心
  • 其他最终用途

第七章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第八章：公司简介

  • Abbott Laboratories
  • AngioDynamics
  • AtriCure
  • Biosense Webster
  • Boston Scientific Corporation
  • Biotronik
  • CardioFocus
  • Getinge
  • Japan Lifeline
  • Karl Storz
  • Lepu Medical Technology
  • Lifetech Scientific
  • Livanova
  • Microport Scientific Corporation
  • Medical Instruments
  • Medtronic
  • Occlutech
  • Saphena Medical
  • Stereotaxis
  • Terumo Corporation
简介目录
Product Code: 4949

The Global Cardiovascular Devices Market was valued at USD 7.5 billion in 2024 and is projected to register a CAGR of 13.5% from 2025 to 2034, driven by rising cases of cardiovascular diseases (CVDs), technological advancements, and increasing healthcare expenditures. The escalating burden of heart-related ailments, largely fueled by an aging population and lifestyle-related disorders, is significantly propelling demand for advanced cardiovascular solutions. As sedentary habits, poor dietary choices, and high-stress levels continue to contribute to CVDs worldwide, the need for innovative diagnostic and treatment devices is becoming more pressing than ever. Additionally, greater awareness regarding preventive healthcare and early detection strategies is further boosting market adoption.

Cardiovascular Devices Market - IMG1

Cutting-edge advancements in medical technology are revolutionizing cardiovascular care. The introduction of AI-powered diagnostics, robotic-assisted surgeries, and minimally invasive procedures is enhancing patient outcomes while reducing recovery time. The industry is witnessing a surge in regulatory approvals, expanding access to state-of-the-art cardiovascular devices. Governments and private healthcare entities are heavily investing in research and development to introduce next-generation solutions that cater to evolving patient needs. Rising healthcare expenditures, particularly in developed economies, are facilitating the widespread availability of advanced cardiac devices, further propelling market growth. Moreover, the increasing number of outpatient cardiovascular interventions and home-based monitoring systems is making treatments more accessible and convenient for patients.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$7.5 Billion
Forecast Value$26.3 Billion
CAGR13.5%

The market is categorized by device type into cardiac ablation devices, left atrial appendage closure devices, and endoscopic vessel harvesting devices. Among these, cardiac ablation devices led the market with a valuation of USD 5.1 billion in 2024 and are projected to witness a CAGR of 13.7% over the forecast period. The rising prevalence of atrial fibrillation is a key driver behind the demand for these devices. With more individuals diagnosed with irregular heart rhythms, the adoption of minimally invasive ablation techniques is on the rise. Additionally, growing awareness about effective treatment options, coupled with continuous advancements in ablation technology, is fostering market expansion.

By end use, the cardiovascular devices market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and other healthcare facilities. Hospitals dominated the sector, generating USD 4.4 billion in 2024 and accounting for 58.3% of the total revenue. A higher patient influx for complex cardiac interventions, including bypass surgeries, catheterizations, and device implantations, is solidifying hospitals' leadership in this space. Equipped with advanced imaging technologies, specialized cardiac units, and multidisciplinary teams, hospitals remain the primary treatment hubs for critical cardiovascular cases. Additionally, their ability to handle emergency and inpatient procedures makes them a preferred choice among both patients and healthcare providers.

The U.S. cardiovascular devices market stood at USD 2.5 billion in 2023 and is projected to grow to USD 9.7 billion by 2034. The country benefits from a well-established healthcare infrastructure, rapid adoption of cutting-edge cardiovascular technologies, and a strong network of skilled professionals, including cardiac surgeons, interventional cardiologists, and electrophysiologists. Continuous innovation in treatment methodologies and supportive regulatory policies are accelerating market penetration. Favorable reimbursement frameworks are further encouraging the adoption of advanced cardiovascular devices, positioning the U.S. as a leading market for cardiac care solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of patients suffering from cardiovascular diseases
      • 3.2.1.2 Expanding geriatric population
      • 3.2.1.3 Rising government initiatives
      • 3.2.1.4 Technological advancements in cardiovascular devices
      • 3.2.1.5 Rising demand for minimally invasive procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High risk associated with cardiac procedures
      • 3.2.2.2 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cardiac ablation devices
    • 5.2.1 Radiofrequency ablators
    • 5.2.2 Electric ablators
    • 5.2.3 Cryoablation devices
    • 5.2.4 Ultrasound devices
    • 5.2.5 Other cardiac ablation devices
  • 5.3 Left atrial appendage closure devices
    • 5.3.1 Endocardial LAA closure devices
    • 5.3.2 Epicardial LAA closure devices
  • 5.4 Endoscopic vessel harvesting devices
    • 5.4.1 EVH systems
    • 5.4.2 Endoscopes
    • 5.4.3 Accessories

Chapter 6 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Ambulatory surgical centers
  • 6.4 Cardiac centers
  • 6.5 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
  • 8.2 AngioDynamics
  • 8.3 AtriCure
  • 8.4 Biosense Webster
  • 8.5 Boston Scientific Corporation
  • 8.6 Biotronik
  • 8.7 CardioFocus
  • 8.8 Getinge
  • 8.9 Japan Lifeline
  • 8.10 Karl Storz
  • 8.11 Lepu Medical Technology
  • 8.12 Lifetech Scientific
  • 8.13 Livanova
  • 8.14 Microport Scientific Corporation
  • 8.15 Medical Instruments
  • 8.16 Medtronic
  • 8.17 Occlutech
  • 8.18 Saphena Medical
  • 8.19 Stereotaxis
  • 8.20 Terumo Corporation